Eikon Therapeutics, Inc. · NASDAQ:EIKN
Eikon Therapeutics, Inc. shareholders
As of Sep 30, 2026, 92 institutions reported holding Eikon Therapeutics, Inc., 58.5% of its shares. Largest: Fidelity, BlackRock and T. Rowe Price. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Eikon Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Fidelity | 5.52M | 10.2% | +526K | Nov 10, 2026 |
| BlackRock | 4.87M | 9.0% | +588K | Nov 13, 2026 |
| T. Rowe Price | 2.75M | 5.1% | +148K | Nov 16, 2026 |
| Foresite Capital Management IV, LLC | 1.94M | 3.6% | no change | Nov 16, 2026 |
| Merck & Co., Inc. | 1.67M | 3.1% | no change | Nov 13, 2026 |
| Vanguard | 1.45M | 2.7% | +224K | Nov 13, 2026 |
| Foresite Capital Management V, LLC | 1.32M | 2.4% | no change | Nov 16, 2026 |
| Capital Group | 1.18M | 2.2% | no change | Nov 12, 2026 |
| AllianceBernstein | 1.05M | 1.9% | +410K | Nov 16, 2026 |
| EcoR1 Capital, LLC | 856K | 1.6% | +123K | Nov 16, 2026 |